Total: 1 |
|
PMID (PMCID) | ||
---|---|---|
24630585 |
FEMALE | Middle Aged |
[Paradoxical cutaneous reactions associated with tocilizumab therapy]. | ||
Sparsa L, Afif N, Bularca S, Fricker A, Thiebault S, Dahan E, Wendling D, Sibilia J, Ardizzone M. Rev Med Interne. 2014;35(9):613-6. |
||
Tocilizumab (TCZ) is a humanized antihuman interleukin (IL)-6 receptor antibody recommended for the treatment of moderate to severe active rheumatoid arthritis, adult-onset Still disease, Castleman disease and more recently, systemic juvenile idiopathic arthritis. |